Raymond James & Associates Adma Biologics, Inc. Call Options Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 14, 2021
SELL
$1.67 - $2.95 $5,010 - $8,850
-3,000 Reduced 16.67%
15,000 $1,000
Q4 2020

Feb 12, 2021
BUY
$1.8 - $2.56 $1,800 - $2,560
1,000 Added 5.88%
18,000 $1,000
Q3 2020

Nov 04, 2020
BUY
$2.04 - $3.74 $34,680 - $63,580
17,000 New
17,000 $1,000

Others Institutions Holding ADMA

# of Institutions
312
Shares Held
184M
Call Options Held
917K
Put Options Held
91.6K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email